Literature DB >> 25493139

Tracheal-mediastinal fistula post-chemoradiation therapy.

Joseph McCarthy1, Jason Hamel1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25493139      PMCID: PMC4251240          DOI: 10.5811/westjem.2014.8.23438

Source DB:  PubMed          Journal:  West J Emerg Med        ISSN: 1936-900X


× No keyword cloud information.

INTRODUCTION

A 52-year-old male presented to the emergency department with chest pain, shortness of breath and hemoptysis that had been worsening over the past two days. Past medical history included a history of non-small cell lung carcinoma, which he had completed radiation therapy approximately four months prior and was currently undergoing chemotherapy. Significant vitals upon presentation included a respiration rate of thirty-six breaths/min and peripheral oxygen saturation measuring 80%. Physical examination revealed a cachectic male appearing older than his actual age, alert and oriented to person, place and time with rhonchi throughout his lung fields and decreased breath sounds on the right. He was started on non-invasive biphasic positive airway pressure with mild improvement of clinical status. An anteriorposterior chest radiograph was preformed and prior computed tomography of the chest was reviewed (Figures 1, 2). Computed tomography of the chest was also repeated on the day of presentation (Figure 3).
Figure 1

Anteriorposterior chest radiograph displaying lucency adjacent to the aortic knob (arrow) and left cardiac border (arrowhead) consistent with pneumomediastinum.

Figure 2

Coronal computed tomography of paratracheal mass with right anterolateral trachaeal involvement.

Figure 3

Coronal computed tomography exhibiting a deficit in the right tracheal wall with a cavitary space previously occupied by the large soft tissue mass seen in Figure 2.

DISCUSSION

There are reports of high incidences of tracheoesophageal fistula formation in patients being treated for lung cancers with the combination of radiation therapy and chemotherapies, notably bevacizumab,1 but tracheal-mediastinal fistulas are rare.2 Patient’s presentation can vary from acute tension pneumothorax and asphyxiation from pulmonary flooding secondary to hemorrhage, to insidious wasting, malaise, fever, or chronic cough.3 Acquired fistulas of the tracheobronchial airways are associated with high rates of morbidity and mortality, with many patients dying from hemorrhage resulting from progression of the fistula into the blood vessels.2 Emergent intubation is often required with the understanding that this may cause or worsen hemoptysis leading to possible cardiovascular and respiratory failure. There is lack of consensus for optimal definitive therapy, but options include open surgery, bronchoscopically placed expandable stents, fibrin glue, and even autologous adipose-derived stem cells.2,3 After discussion with the patient and family regarding the diagnosis, he preferred not to be intubated and requested only supportive care. He was admitted to the hospital on biphasic non-invasive positive airway pressure and expired from respiratory failure shortly thereafter.
  3 in total

Review 1.  Bronchopleural fistulas: an overview of the problem with special focus on endoscopic management.

Authors:  Manuel Lois; Marc Noppen
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

2.  Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.

Authors:  David R Spigel; John D Hainsworth; Denise A Yardley; Eric Raefsky; Jeffrey Patton; Nancy Peacock; Cindy Farley; Howard A Burris; F Anthony Greco
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

3.  A new bronchoscopic treatment of tracheomediastinal fistula using autologous adipose-derived stem cells.

Authors:  P Díaz-Agero Alvarez; M García-Arranz; T Georgiev-Hristov; D García-Olmo
Journal:  Thorax       Date:  2008-04       Impact factor: 9.139

  3 in total
  4 in total

1.  Malignant tracheal necrosis and fistula formation following palliative chemoradiotherapy: a case report.

Authors:  In Ae Kim; Hyeon Kang Koh; Sun Jong Kim; Kwang Ha Yoo; Kye Young Lee; Hee Joung Kim
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Tracheomediastinal Fistula: Rare Complication of Treatment with Bevacizumab.

Authors:  Rajat Thawani; Anna Thomas; Kshitij Thakur
Journal:  Cureus       Date:  2018-04-03

3.  Nivolumab therapy for lung cancer with tracheo-parenchymal fistula: A case report.

Authors:  Masahiro Yamasaki; Wakako Daido; Kunihiko Funaishi; Kazuma Kawamoto; Yu Matsumoto; Naoko Matsumoto; Masaya Taniwaki; Nobuyuki Ohashi; Noboru Hattori
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

4.  Tracheo-parenchymal fistula following concurrent chemo-radiation for stage III NSCLC.

Authors:  Bashar Alzghoul; Nikhil Meena
Journal:  Respir Med Case Rep       Date:  2016-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.